Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2000
12/21/2000CA2376667A1 Gene expression modulated in gastrointestinal inflammation
12/21/2000CA2376609A1 Method for determining hiv-1 subtype
12/21/2000CA2376523A1 Dna pcv-vaccine
12/21/2000CA2376479A1 Retro-inverso peptides derived from interleukin-6
12/21/2000CA2376474A1 Retro-inverso peptides derived from leukemia inhibitory factor
12/21/2000CA2376473A1 Glp-1 as a diagnostic test to determine b-cell function and the presence of the condition of igt and type-ii diabetes
12/21/2000CA2376432A1 Novel protein and dna thereof
12/21/2000CA2376421A1 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
12/21/2000CA2376394A1 Retro-inverso peptides derived from interleukin-3
12/21/2000CA2376392A1 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells
12/21/2000CA2376389A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000CA2376357A1 .mu.o-conopeptides and their use as local anesthetics
12/21/2000CA2376243A1 Gustatory receptors in drosophila
12/21/2000CA2376232A1 A structured peptide scaffold for displaying turn libraries on phage
12/21/2000CA2376142A1 Camello gene family and uses thereof
12/21/2000CA2375998A1 Gene and protein sequences of phage t4 gene 35
12/21/2000CA2375924A1 Compositions and methods for detecting treponema pallidum
12/21/2000CA2375825A1 Complement-resistant non-mammalian dna viruses and uses thereof
12/21/2000CA2375619A1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf)
12/21/2000CA2375386A1 Lipocalin family protein
12/21/2000CA2375346A1 Fibrin sealant as a transfection/transformation vehicle for gene therapy
12/21/2000CA2375320A1 Dna vaccines for pets or for animals used in sports
12/21/2000CA2374909A1 Human intracellular signaling molecules
12/21/2000CA2374678A1 Diagnosis, prognosis and treatment of cancer related to the barx2 gene
12/21/2000CA2374000A1 Use of soluble protein molecules expressed by the pancreas and kidney glomerulus
12/21/2000CA2373628A1 Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism
12/21/2000CA2372558A1 Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c)
12/21/2000CA2370405A1 Nucleic acid molecules from wheat, transgenic plant cells and plants and the use thereof for the production of modified starch
12/20/2000EP1061129A1 Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses
12/20/2000EP1060745A2 A composition and method for treating bacterial infection
12/20/2000EP1060261A1 Poly zinc finger proteins with improved linkers
12/20/2000EP1060259A2 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
12/20/2000EP1060257A1 Method for the induction of pathogen resistance in plants
12/20/2000EP1060254A2 Human proteinase molecules
12/20/2000EP1060249A1 Epitope peptides immunogenic against streptococcus pneumoniae
12/20/2000EP1060248A1 Lectomedin materials and methods
12/20/2000EP1060247A1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
12/20/2000EP1060194A1 Enhancing the circulating half-life of antibody-based fusion proteins
12/20/2000EP1060193A2 Cd147 binding molecules as therapeutics
12/20/2000EP1060192A2 Glp-2 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates
12/20/2000EP1060191A1 Derivatives of glp-1 analogs
12/20/2000EP1060185A1 Isolated nucleic acid molecules which encode tage molecules, and uses thereof
12/20/2000EP1060184A1 Best's macular dystrophy gene
12/20/2000EP1059929A2 Isolated stromal cells for use in the treatment of diseases of the central nervous system
12/20/2000EP0823848A4 Tissue adhesive using synthetic cross-linking
12/20/2000EP0671934B1 Method of treating cell damage or depletion
12/20/2000CN1277635A Nucleic acids having promoter activity and transgenic plants containing the same
12/20/2000CN1277634A New tissue-specific calpaines, their production and their use
12/20/2000CN1277633A Mutants of thyroid stimulating hormone and methods based thereon
12/20/2000CN1277616A Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor
12/20/2000CN1277615A Protein composition and process for isolating a protein composition from a muscle source
12/20/2000CN1277614A Mammaglobin a secreted mammary-specific breast cancer protein
12/20/2000CN1277208A New angio-auxin derivative protein and its code sequence
12/20/2000CN1277207A Phytase with heat tolerance
12/20/2000CN1277206A Purification technology for hepatitis B surface gene fusion antigen containing S-main protein and pre-S1-macroprotein
12/20/2000CN1277061A Preparation of oral collagen with gradient molecular weight
12/20/2000CN1059705C Composition for introducing nucleic acid complexes into higher eucaryotic cells
12/19/2000US6162967 Positional cloning of soybean cyst nematode resistance genes
12/19/2000US6162965 Plant transformation methods
12/19/2000US6162964 Promoter which causes transcription in cells critical to pollen formation or function and a dna sequence encoding a gene product which converts nontoxic substance to cytotoxic one; simple and efficient production of stable hybrid seeds
12/19/2000US6162907 Dna and amino acid sequence of derivative of glucagon-like peptide i; antidiabetic agents for treatment of type ii diabetes mellitus
12/19/2000US6162905 FSH and LH separation and purification process
12/19/2000US6162903 Immunoglobulin binding proteins derived from L protein and their uses
12/19/2000US6162902 Reactive to epitopes of human brain natriuretic peptide; rapid and sensitive quantification in plasma or serum
12/19/2000US6162901 Vesicle transport protein
12/19/2000US6162900 Amino acid sequences of polypeptide which transports cadmium, iron(ii), cobalt, manganese, lead, mercury, and zinc; transgenic plants with increased metal uptake for use as nutrient supplements or removing toxic metals from soils
12/19/2000US6162899 Human HNEAA81 receptor
12/19/2000US6162898 Mutant Rev transdominant repressors of HIV replication
12/19/2000US6162897 17q-linked breast and ovarian cancer susceptibility gene
12/19/2000US6162896 Isolated polypeptide encoded by a defined nucleotide sequence; antitumor agents; wound healing agents; immunosuppressants; diagnosis and treatment of immune, reproductive, or central nervous system disorders
12/19/2000US6162895 For prolonged control of hyperglycemia
12/19/2000US6162789 Frozen food product
12/19/2000US6162788 Chlamydia intracellular inclusion bodies in cells
12/19/2000US6162785 Polypeptide with amino acid sequence
12/19/2000US6162641 Nucleotide sequence derived from a promoter sequence and operably linked to a heterologous gene; for controlled gene expression
12/19/2000US6162632 OxlT sequence and its use
12/19/2000US6162631 Retrovirus from the HIV group and its use (MVP-2901/94)
12/19/2000US6162625 Phenylalanyl tRNA synthetase from streptococcus pneumoniae
12/19/2000US6162620 Nucleotide sequences coding human cytomegalo viral polypeptides; for the development of preventative against human cytomegalo viral infection
12/19/2000US6162617 Streptococcus pneumoniae gene sequence dnaG
12/19/2000US6162616 Multidrug resistance-associated polypeptide
12/19/2000US6162612 Enzymatic polypeptide; for te detection of enzyme inhibitor which can be used to treat cancer, psoriasis and vascular system defects; anticarcinogenic agents
12/19/2000US6162608 Nuclear matrix protein fluid assay
12/19/2000US6162604 Detecting genetic disorder associated with autoimmune disease; obtain human sample and screen for the presence of preferential alleles, the presence of alleles indicates sensitivity to autoimmune disease
12/19/2000US6162601 Nucleotide sequence coding mammalian polypeptide; for the diagnosis, prevention, and treatment of developmental, vesicle transportation, tumors and immunnological defects; antitumor agents
12/19/2000US6162461 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
12/19/2000US6162440 Variant competes with ebna2 protein for cbf1, a cellular dna-binding protein; ebna2 is a transcriptional activator that regulates viral latency gene expression and activates expression of cellular genes; suppressing epstein-barr virus
12/19/2000US6162439 An isolated polypeptides derived from novel lentiviruses for the detection of aids
12/19/2000US6162436 Compositions and methods using complexes of heat shock protein 90 and antigenic molecules for the treatment and prevention of neoplastic diseases
12/19/2000US6162435 A isolated protein for treating swine; a diagnostic test kit for detecting the presence of bacterial infection in swine herds
12/19/2000US6162434 Cytomodulating peptide for inhibiting lymphocyte activity
12/19/2000US6162432 Increased t cell activation and abnormal antigen in the dermis and epidermis
12/19/2000US6162430 At least two different insecticide proteins provide synergistic control
12/19/2000US6162429 Biologically pure serpens spp. strain hbl-112 (atcc 202005); treating infectious disease of the feet and/or lower legs of cattle
12/19/2000CA2145881C Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
12/19/2000CA2067244C Monoclonal antibody specific for iga receptor
12/19/2000CA2000420C Peptides representing epitopic sites on r-ifn-beta, antibodies thereto, and uses thereof
12/14/2000WO2000075670A1 Interaction of b3-1 with adp-ribosylation factor gtp exchange factors
12/14/2000WO2000075665A1 Early detection of flaviviruses using the ns1 glycoprotein
12/14/2000WO2000075655A1 Screening method with the use of cd100
1 ... 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 ... 2916